Publication | Open Access

Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial

Open-label TrialHypertensionCardiovascular DiseaseAntihypertensive TherapyClinical TrialsCardiovascular PharmacologyRenin–angiotensin System InhibitorsTreatment OptionPharmacotherapyMedicineCovid-19